Trimethoprim‐Sulfamethoxazole as a Viable Treatment Option for Infections Caused by Methicillin‐Resistant Staphylococcus aureus

@article{Grim2005TrimethoprimSulfamethoxazoleAA,
  title={Trimethoprim‐Sulfamethoxazole as a Viable Treatment Option for Infections Caused by Methicillin‐Resistant Staphylococcus aureus},
  author={S. Grim and R. Rapp and C. Martin and M. Evans},
  journal={Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year={2005},
  volume={25}
}
  • S. Grim, R. Rapp, +1 author M. Evans
  • Published 2005
  • Medicine
  • Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
  • Objective. To review available data regarding the efficacy of trimethoprim‐sulfamethoxazole (TMP‐SMX) for the treatment of infections caused by methicillin‐resistant Staphylococcus aureus (MRSA). 
    90 Citations
    New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus.
    • E. Bouza
    • Biology, Medicine
    • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
    • 2009
    • 19
    Methicillin-Resistant Staphylococcus aureus: A Review of Current Antibiotic Therapy
    • 2
    • Highly Influenced
    • PDF
    Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.
    • R. Proctor
    • Medicine
    • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    • 2008
    • 127
    • PDF

    References

    SHOWING 1-10 OF 111 REFERENCES
    Trimethoprim-Sulfamethoxazole Treatment of Multiantibiotic-Resistant Staphylococcal Endocarditis and Meningitis
    • 12
    Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid.
    • 93
    • PDF
    The emergence of methicillin-resistant Staphylococcus aureus.
    • R. Wenzel
    • Medicine
    • Annals of internal medicine
    • 1982
    • 106